Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how

MarketBeat.com MarketBeat.com

MarketBeat.com's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by MarketBeat.com, including current material.
4 Hot Midcaps That the Insiders Are Buying By Thomas Hughes - Jan 10, 2024

Envista Holdings insiders are buying, but investors should wait for the next decline before buying in. Curtiss-Wright is in a sustained uptrend with growth in the forecast and analysts supporting the...

2 Low-Priced Gene Therapy Stocks to Speculate On By Jea Yu  - Jan 09, 2024

Bluebird Bio has three FDA-approved gene therapy treatments that are planning to commercialize after its $150 million secondary offering of common shares priced at $1.50 per share. Bluebird bio's...

ConAgra Is Still a Value Investor’s Dream By Jea Yu  - Jan 02, 2024

ConAgra is a major manufacturer of packaged and frozen foods selling under iconic brands like Birds Eye, Slim Jim, Vlasic, Reddi-wip, and Orville Redenbacher. It produced its sixth consecutive...

Rivian Is All Set to Start 2024 With a Bang By Sam Quirke  - Dec 29, 2023

The stock had a bumpy 2023 but is ending the year well ahead of its peers. Several key tailwinds are in place, which should support further gains. Aside from perhaps Tesla, Rivian remains one of the...

Continue with Google
or
Sign up with Email